For Healthcare Professionals

Investigator-sponsored trials


In line with our mission to improve cancer care, we support external clinical research that advances medical or scientific knowledge about our therapies.

Our Investigator-Sponsored Trials (IST) program provides funding and/or study drug for clinical research that:

  • Generates new scientific data to address unmet medical needs
  • Explores the feasibility of new investigational treatments through pilot studies
Program Criteria and Process

Submitting a proposal

Proposals are accepted on an ongoing basis via our online portal. If you would like to submit a proposal related to enfortumab vedotin research, please visit the Astellas Investigator-Sponsored Research portal. Enfortumab vedotin proposals are reviewed jointly by Seagen and Astellas.

Seagen will generally review your proposal within 45 to 60 days of submission. You will receive an email notification upon approval or denial. If your proposal is accepted, a full protocol and budget will be requested within 90 days.

Learn more about ISTs

For questions about this program, our process, or your proposed research, please contact your regional Medical Science Liaison (MSL) or email IST@seagen.com.

Access scientific and clinical resources

Healthcare professionals in the United States can access recent congress presentations, videos about our science, and more on our medical affairs website.

Explore the Medical Affairs Website